Gene: RNF150
Official Full Name: ring finger protein 150provided by HGNC
Gene Summary: Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent protein catabolic process. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14464 | RNF150 Knockout cell line (HeLa) | Human | RNF150 | 1:3~1:6 | Negative | Online Inquiry |
KO14465 | RNF150 Knockout cell line (HEK293) | Human | RNF150 | 1:3~1:6 | Negative | Online Inquiry |
RNF150 Gene Knockout Cell Lines are a specialized biological product designed to facilitate the study of the RNF150 gene's function and its implications in various cellular processes. RNF150 is known to encode a RING finger protein that plays a critical role in the regulation of cellular pathways, including immune responses and protein ubiquitination. The knockout of this gene allows researchers to observe phenotypic and molecular changes that occur in the absence of its functional product, providing insights into the gene's specific contributions within biological systems.
These cell lines work through innovative CRISPR-Cas9 technology, which enables precise genomic editing to create targeted deletions, thereby enabling the complete loss of RNF150 expression. This is particularly significant for understanding its role in cancer biology, autoimmune diseases, and other pathologies where aberrations in ubiquitination processes may play a pivotal role. By utilizing these knockout cell lines, researchers can explore the mechanistic underpinnings of RNF150 in various contexts, promoting advancements in therapeutic strategies that target related signaling pathways.
The scientific importance of RNF150 Gene Knockout Cell Lines is underscored by their applications in both fundamental and applied research, making them invaluable for studying gene function and validating potential drug targets. Their unique selling points include the reliability of the cellular environment provided and the specificity of gene modification, which are often superior to other gene-editing methods that may lead to off-target effects.
For researchers and clinicians focused on advancing their work in molecular and cell biology, the RNF150 Gene Knockout Cell Lines are essential tools that enhance experimental rigor and reproducibility. They enable teams to generate robust data that could influence both basic research and clinical applications, including biomarker discovery and drug development.
Our company specializes in producing high-quality biological products, ensuring that our customers receive the most reliable tools for their research needs. With state-of-the-art technologies and deeply rooted expertise in gene editing, we are committed to supporting scientific advancement through innovative solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.